Skip to main content

Inovalon ONE® Platform Selected by Cardinal Health

Written by Customer Service on . Posted in Public Companies.

BOWIE, Md., June 16, 2020 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a five-year engagement with Cardinal Health, Inc. (NYSE: CAH), a global integrated healthcare services and products company, to provide a configuration of Inovalon’s ScriptMed® Cloud. The platform will be used to support Cardinal Health’s durable medical equipment (DME) and medical supplies business, which works to provide superior care in the home.
DME, a sub-segment within the pharmacy marketplace, is a uniquely high-value segment of the health care ecosystem that is of increasing importance to payers, pharmaceutical companies, and patients alike. As the number of elderly, chronically ill, and patients with complex care conditions continues to rise in the United States, the DME marketplace is projected to grow from $49 billion in 2019 to more than $79 billion by 2027. The need to support increasingly complex and patient-specific care protocols while focusing on cost efficiency is a meaningful pressure for this rapidly growing market segment. Through the implementation of ScriptMed® Cloud, a software-as-a-service (SaaS) cloud offering configured to optimize the unique servicing needs of DME products through the pharmacy benefit, the Inovalon ONE® Platform’s connectivity, supplemental clinical data, and process-specific analytics automate otherwise labor-intensive processes, pre-populate relevant clinical data, seamlessly apply appropriate care protocol analytics, and streamline operational process flows – ultimately enabling improvements both in quality of care and operating expense efficiency in large scale.“As the cost of medication, services and devices required for patient treatment plans in the pharmacy segment continues to expand, the sophistication of the technologies needed to achieve meaningful and differentiated results for patients is also increasing,” said Matt Brow, president and general manager of the pharmacy, life sciences and advisory business units at Inovalon. “We are very pleased to bring the capabilities of ScriptMed® Cloud to bear with an industry leader such as Cardinal Health to empower better patient outcomes and economics.”“Cardinal Health is investing in the digital forefront of technologies to deliver high-quality care to our customers,” said Ryan Schorr, general manager of the direct-to-patient business at Cardinal Health. “Implementing the capabilities of ScriptMed® Cloud will enable both meaningful operational efficiencies and a best-in-class experience for the patients we support.”About ScriptMed® CloudScriptMed® Cloud is the next generation technology for specialty patient care, empowered by the latest and most advanced capabilities of the Inovalon ONE® Platform. These advancements include increased modularity, high-speed cloud-based compute, multi-stakeholder workflows, real-time healthcare ecosystem connectivity; advanced analytics and enhanced data visualization capabilities, and leverage Inovalon’s massive datasets. ScriptMed® Cloud delivers differentiated value in the specialty market, meaningfully reducing time-to-fill, reducing costs and error rates, while empowering advanced functionality, greater flexibility, operational efficiency, and a focus on clinical and quality outcomes, delivering impactful savings and financial benefits for the specialty pharmacy marketplace and the patients who are served. ScriptMed® Cloud is a cloud native architecture provided to clients in a pure software-as-a-service (SaaS) offering model.About the Inovalon ONE® PlatformThe Inovalon ONE® Platform is an integrated cloud-based platform of nearly 100 individual proprietary technology toolsets and deep data assets able to be rapidly configured to empower the operationalization of large-scale, data-driven healthcare initiatives. Each proprietary technology toolset, referred to as a Module, is informed by the data of billions of medical events within Inovalon’s proprietary datasets. Combinations of Modules are configured to empower highly differentiated solutions for client needs quickly and in a highly scalable fashion. The flexibility of the Platform’s modular design enables clients to integrate the Platform capabilities with their own internal capabilities or other third-party solutions. The Platform brings to the marketplace a highly extensible, national-scale capability to interconnect with the healthcare ecosystem on a massive scale, aggregate and analyze data in petabyte volumes, arrive at sophisticated insights in real time, and drive meaningful impact wherever it is analytically identified best to intervene and intuitively visualize data and information to inform business strategy and execution.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million Americans, and 55 billion medical events. For more information, visit www.inovalon.com.Contact:Kim E. Collins
Senior Vice President, Corporate Communications
kcollins@inovalon.com
301-809-4000 x1473Hulus Alpay
Vice President, Investor Relations
halpay@inovalon.com
301-809-4000 x1237

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.